Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Accumulated Expenses (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Accumulated Expenses data on record, last reported at $292609.0 in Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 106.02% to $292609.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $292609.0, a 106.02% increase, with the full-year FY2024 number at $299514.0, up 1105.72% from a year prior.
  • Accumulated Expenses reached $292609.0 in Q3 2025 per AFJK's latest filing, down from $309097.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for AFJK hit a ceiling of $457420.0 in Q1 2025 and a floor of $24841.0 in Q4 2023.
  • A 3-year average of $207997.4 and a median of $217317.5 in 2024 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 1105.72% in 2024, then soared 106.02% in 2025.
  • Tracing AFJK's Accumulated Expenses over 3 years: stood at $24841.0 in 2023, then skyrocketed by 1105.72% to $299514.0 in 2024, then fell by 2.31% to $292609.0 in 2025.
  • Business Quant data shows Accumulated Expenses for AFJK at $292609.0 in Q3 2025, $309097.0 in Q2 2025, and $457420.0 in Q1 2025.